PHASES
0
0
0
0
Phase I
Safety Study (20 – 80 people)
Phase II
Safety Study
Identify Side Effects
Measure Effectiveness
(100 – 300 people)
Phase III
Measure Effectiveness
Monitor Side Effects
(1000 – 3000 people)
Phase IV
Monitor Long Term Side Effects
0
Phase I
Safety Study (20 – 80 people)
0
Phase II
Safety Study
Identify Side Effects
Measure Effectiveness
(100 – 300 people)
0
Phase III
Measure Effectiveness
Monitor Side Effects
(1000 – 3000 people)
0
Phase IV
Monitor Long Term Side Effects